CORC

浏览/检索结果: 共124条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Complex Dynamic Neurons Improved Spiking Transformer Network for Efficient Automatic Speech Recognition 会议论文
Washington D.C., USA, 2023-2-9
作者:  Qingyu Wang;  Tielin Zhang;  Minglun Han;  Yi Wang;  Duzhen Zhang
收藏  |  浏览/下载:16/0  |  提交时间:2023/06/20
An End-to-end Structure with CTC Encoder and OCD Decoder For Speech Recognition 会议论文
Graz, Austria, 2019-9
作者:  Cheng, Yi;  Feng, Wang;  Bo, Xu
收藏  |  浏览/下载:7/0  |  提交时间:2021/06/21
Efficient and Accurate Face Shape Reconstruction by Fusion of Multiple Landmark Databases 会议论文
Taipei, Taiwan, 2019-9-22~2019-9-25
作者:  Wang, Pengrui;  Tian, Yi;  Che, Wujun;  Xu, Bo
收藏  |  浏览/下载:9/0  |  提交时间:2020/09/11
A Unified Multi-output Semi-supervised Network for 3D Face Reconstruction 会议论文
Budapest, 2019-07
作者:  Wang, Pengrui;  Tian, Yi;  Che, Wujun;  Xu, Bo
收藏  |  浏览/下载:7/0  |  提交时间:2020/09/11
Simulation study on liquid-end of high-pressure and large-flow-rate reciprocating pump 会议论文
Wuhan, China, April 10, 2019 - April 13, 2019
作者:  Ran, Li;  Wei, Wenshu;  Hao, Liu;  Yi, Zhu;  Hong, Ji
收藏  |  浏览/下载:1/0  |  提交时间:2020/11/15
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:45/0  |  提交时间:2019/12/05
The sixth visual object tracking VOT2018 challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Kristan, Matej;  Leonardis, Ale;  Matas, Jií;  Felsberg, Michael;  Pflugfelder, Roman
收藏  |  浏览/下载:140/0  |  提交时间:2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:34/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace